Archives

by in
Entry Author Date Location
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
NJ’s Medicine Chest Thins Again as GE Health Unit Heads for MA 08/19/14 Boston
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Novartis Helps Pour $16M Into Seventh Sense for Pain-Free Blood Tests 08/13/14 Boston
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
G1, Out to Shield Body From Chemo, Heads to First Clinical Test 07/28/14 Raleigh Durham
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor 06/19/14 Boston
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
Tamr Emerges With $16M to Crack Data Curation for Enterprises 05/19/14 Boston
East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More 05/16/14 Boston
With Novartis Deal Dead, Proteon Embarks on Plan B With $45M Round 05/16/14 Boston
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone 03/18/14 Boston
Five Prime, Bristol-Myers Squibb Cut $350M Immuno-Oncology Deal 03/17/14 San Francisco
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day 02/24/14 National
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Juno Therapeutics Adds Jeff Bezos, Venrock to $145M Venture Deal 01/13/14 Seattle
Blueprint Medicines Hauls in $25M For Cancer Drug Push 01/07/14 Boston
Page 2 of 14 « previous page · next page »